The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
MicroRNA‐146a contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins
Abstract
Objective: MicroRNA have recently been identified as regulators that modulate target gene expression and are involved in shaping the immune response. This study was undertaken to investigate the contribution of microRNA‐146a (miR‐146a), which was identified in the pilot expression profiling step, to the pathogenesis of systemic lupus erythematosus (SLE). Methods: TaqMan microRNA assays of peripheral blood leukocytes were used for comparison of expression levels of microRNA between SLE patients and controls. Transfection and stimulation of cultured cells were conducted to determine the biologic function of miR‐146a. Bioinformatics prediction and validation by reporter gene assay and Western blotting were performed to identify miR‐146a targets. Results: Profiling of 156 miRNA in SLE patients revealed the differential expression of multiple microRNA, including miR‐146a, a negative regulator of innate immunity. Further analysis showed that underexpression of miR‐146a negatively correlated with clinical disease activity and with interferon (IFN) scores in patients with SLE. Of note, overexpression of miR‐146a reduced, while inhibition of endogenous miR‐146a increased, the induction of type I IFNs in peripheral blood mononuclear cells (PBMCs). Furthermore, miR‐146a directly repressed the transactivation downstream of type I IFN. At the molecular level, miR‐146a could target IFN regulatory factor 5 and STAT‐1. More importantly, introduction of miR‐146a into the patients' PBMCs alleviated the coordinate activation of the type I IFN pathway. Conclusion: The microRNA miR‐146a is a negative regulator of the IFN pathway. Underexpression of miR‐146a contributes to alterations in the type I IFN pathway in lupus patients by targeting the key signaling proteins. The findings provide potential novel strategies for therapeutic intervention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
The 1982 revised criteria for the classification of systemic lupus erythematosus
Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., Mcshane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., & Winchester, R. J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780251101 · Cited by 14,519
Lewis, B. P., Burge, C. B., & Bartel, D. P. (2005) · Cell · doi:10.1016/j.cell.2004.12.035 · Cited by 11,855
Real-time quantification of microRNAs by stem-loop RT-PCR
Chen, C. (2005) · Nucleic Acids Research · doi:10.1093/nar/gni178 · Cited by 4,952
Derivation of the sledai. A disease activity index for lupus patients
Bombardier, C., Gladman, D. D., Urowitz, M. B., Caron, D., Chang, C. H., Austin, A., Bell, A., Bloch, D. A., Corey, P. N., Decker, J. L., et al. (1992) · Arthritis & Rheumatism · doi:10.1002/art.1780350606 · Cited by 4,570
Taganov, K. D., Boldin, M. P., Chang, K.-J., & Baltimore, D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605298103 · Cited by 4,317
Mechanisms of type-I- and type-II-interferon-mediated signalling
Platanias, L. C. (2005) · Nature Reviews Immunology · doi:10.1038/nri1604 · Cited by 3,491
Baechler, E. C., Batliwalla, F. M., Karypis, G., Gaffney, P. M., Ortmann, W. A., Espe, K. J., Shark, K. B., Grande, W. J., Hughes, K. M., Kapur, V., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0337679100 · Cited by 2,240
Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus Blood
Bennett, L., Palucka, A. K., Arce, E., Cantrell, V., Borvak, J., Banchereau, J., & Pascual, V. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021553 · Cited by 1,958
Negative regulation of Toll-like receptor-mediated immune responses
Liew, F. Y., Xu, D., Brint, E. K., & O'Neill, L. A. J. (2005) · Nature Reviews Immunology · doi:10.1038/nri1630 · Cited by 1,509
Cited by
Epigenetics and gene expression
Gibney, E. R., & Nolan, C. M. (2010) · Heredity · doi:10.1038/hdy.2010.54 · Cited by 1,109
Function of miR-146a in Controlling Treg Cell-Mediated Regulation of Th1 Responses
Lu, L.-F., Boldin, M. P., Chaudhry, A., Lin, L.-L., Taganov, K. D., Hanada, T., Yoshimura, A., Baltimore, D., & Rudensky, A. Y. (2010) · Cell · doi:10.1016/j.cell.2010.08.012 · Cited by 849
Biological functions of microRNAs: a review
Huang, Y., Shen, X. J., Zou, Q., Wang, S. P., Tang, S. M., & Zhang, G. Z. (2011) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-010-0050-6 · Cited by 652
MicroRNAs: History, Biogenesis, and Their Evolving Role in Animal Development and Disease
Bhaskaran, M., & Mohan, M. (2014) · Veterinary Pathology · doi:10.1177/0300985813502820 · Cited by 605
Autoimmunity and organ damage in systemic lupus erythematosus
Tsokos, G. C. (2020) · Nature Immunology · doi:10.1038/s41590-020-0677-6 · Cited by 580
Pan, W., Zhu, S., Yuan, M., Cui, H., Wang, L., Luo, X., Li, J., Zhou, H., Tang, Y., & Shen, N. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0904060 · Cited by 561
Self-citationPathogenesis of Human Systemic Lupus Erythematosus: A Cellular Perspective
Moulton, V. R., Suarez-Fueyo, A., Meidan, E., Li, H., Mizui, M., & Tsokos, G. C. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.05.006 · Cited by 469
MicroRNA, a new paradigm for understanding immunoregulation, inflammation, and autoimmune diseases
Dai, R., & Ahmed, S. A. (2011) · Translational Research · doi:10.1016/j.trsl.2011.01.007 · Cited by 444
MicroRNA-146a: A Dominant, Negative Regulator of the Innate Immune Response
Saba, R., Sorensen, D. L., & Booth, S. A. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00578 · Cited by 427
miR-146a Is Critical for Endotoxin-induced Tolerance
Nahid, M. A., Pauley, K. M., Satoh, M., & Chan, E. K. L. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.056317 · Cited by 423
Yang, W., Shen, N., Ye, D.-Q., Liu, Q., Zhang, Y., Qian, X.-X., Hirankarn, N., Ying, D., Pan, H.-F., Mok, C. C., et al. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1000841 · Cited by 404
Self-citationMyasthenia gravis: A comprehensive review of immune dysregulation and etiological mechanisms
Berrih-Aknin, S., & Le Panse, R. (2014) · Journal of Autoimmunity · doi:10.1016/j.jaut.2013.12.011 · Cited by 383
Identifying Functional MicroRNAs in Macrophages with Polarized Phenotypes
Graff, J. W., Dickson, A. M., Clay, G., McCaffrey, A. P., & Wilson, M. E. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.327031 · Cited by 367
“Consistent with the fact thatmiRNAs often target the pathways that regulate their expression,miR-146a targets STAT1 (38), an important component of IFN signaling.”
BackgroundRegulating IRFs in IFN Driven Disease
Jefferies, C. A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00325 · Cited by 365
Zhao, S., Wang, Y., Liang, Y., Zhao, M., Long, H., Ding, S., Yin, H., & Lu, Q. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30196 · Cited by 363
Anti-Inflammatory MicroRNAs and Their Potential for Inflammatory Diseases Treatment
Tahamtan, A., Teymoori-Rad, M., Nakstad, B., & Salimi, V. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01377 · Cited by 357
Gao, W., Xiong, Y., Li, Q., & Yang, H. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00508 · Cited by 353
The role of miRNA in inflammation and autoimmunity
Singh, R. P., Massachi, I., Manickavel, S., Singh, S., Rao, N. P., Hasan, S., Mc Curdy, D. K., Sharma, S., Wong, D., Hahn, B. H., et al. (2013) · Autoimmunity Reviews · doi:10.1016/j.autrev.2013.07.003 · Cited by 334
Akhtar, N., Rasheed, Z., Ramamurthy, S., Anbazhagan, A. N., Voss, F. R., & Haqqi, T. M. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27329 · Cited by 331
Cancer and Inflammation: Promise for Biologic Therapy
Demaria, S., Pikarsky, E., Karin, M., Coussens, L. M., Chen, Y.-C., El-Omar, E. M., Trinchieri, G., Dubinett, S. M., Mao, J. T., Szabo, E., et al. (2010) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3181d32e74 · Cited by 325
A trio of microRNAs that control Toll-like receptor signalling
Quinn, S. R., & O'Neill, L. A. (2011) · International Immunology · doi:10.1093/intimm/dxr034 · Cited by 314
The Role of Epigenetics in Autoimmune/Inflammatory Disease
Surace, A. E. A., & Hedrich, C. M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01525 · Cited by 302
Stagakis, E., Bertsias, G., Verginis, P., Nakou, M., Hatziapostolou, M., Kritikos, H., Iliopoulos, D., & Boumpas, D. T. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.139857 · Cited by 301
Are innovation and new technologies in precision medicine paving a new era in patients centric care?
Seyhan, A. A., & Carini, C. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-1864-9 · Cited by 299
Brooks, W. H., Le Dantec, C., Pers, J.-O., Youinou, P., & Renaudineau, Y. (2010) · Journal of Autoimmunity · doi:10.1016/j.jaut.2009.12.006 · Cited by 298
The role of microRNAs in the pathogenesis of autoimmune diseases
Chen, J.-Q., Papp, G., Szodoray, P., & Zeher, M. (2016) · Autoimmunity Reviews · doi:10.1016/j.autrev.2016.09.003 · Cited by 282
miR-146a controls the resolution of T cell responses in mice
Yang, L., Boldin, M. P., Yu, Y., Liu, C. S., Ea, C.-K., Ramakrishnan, P., Taganov, K. D., Zhao, J. L., & Baltimore, D. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20112218 · Cited by 281
miR-146 and miR-155: Two Key Modulators of Immune Response and Tumor Development
Testa, U., Pelosi, E., Castelli, G., & Labbaye, C. (2017) · Non-Coding RNA · doi:10.3390/ncrna3030022 · Cited by 267
Curtale, G., Citarella, F., Carissimi, C., Goldoni, M., Carucci, N., Fulci, V., Franceschini, D., Meloni, F., Barnaba, V., & Macino, G. (2010) · Blood · doi:10.1182/blood-2009-06-225987 · Cited by 263
Luo, X., Yang, W., Ye, D.-Q., Cui, H., Zhang, Y., Hirankarn, N., Qian, X., Tang, Y., Lau, Y. L., de Vries, N., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002128 · Cited by 262
Self-citationLi, J., Wan, Y., Guo, Q., Zou, L., Zhang, J., Fang, Y., Zhang, J., Zhang, J., Fu, X., Liu, H., et al. (2010) · Arthritis Research & Therapy · doi:10.1186/ar3006 · Cited by 261
Saleh, H. A., Yousef, M. H., & Abdelnaser, A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.606069 · Cited by 255
Zhou, H., Huang, X., Cui, H., Luo, X., Tang, Y., Chen, S., Wu, L., & Shen, N. (2010) · Blood · doi:10.1182/blood-2010-04-280156 · Cited by 230
Self-citationThe Role of MicroRNA-146a in the Pathogenesis of the Diabetic Wound-Healing Impairment
Xu, J., Wu, W., Zhang, L., Dorset-Martin, W., Morris, M. W., Mitchell, M. E., & Liechty, K. W. (2012) · Diabetes · doi:10.2337/db12-0145 · Cited by 225
MicroRNA-146a and Human Disease
Li, L., Chen, X.-P., & Li, Y.-J. (2010) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2010.02383.x · Cited by 217
MicroRNAs, new effectors and regulators of NF‐κB
Boldin, M. P., & Baltimore, D. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01089.x · Cited by 199
Wu, S., He, L., Li, Y., Wang, T., Feng, L., Jiang, L., Zhang, P., & Huang, X. (2013) · Journal of Infection · doi:10.1016/j.jinf.2013.05.003 · Cited by 173
Self-citationAltered miR-146a expression in Sjögren’s syndrome and its functional role in innate immunity
Pauley, K. M., Stewart, C. M., Gauna, A. E., Dupre, L. C., Kuklani, R., Chan, A. L., Pauley, B. A., Reeves, W. H., Chan, E. K. L., & Cha, S. (2011) · European Journal of Immunology · doi:10.1002/eji.201040757 · Cited by 169
Omran, A., Peng, J., Zhang, C., Xiang, Q., Xue, J., Gan, N., Kong, H., & Yin, F. (2012) · Epilepsia · doi:10.1111/j.1528-1167.2012.03540.x · Cited by 142
“…miR-146a, have been strongly implicated in the regulation of innate immune, viral, and inflammatory responses (Lukiw & Pogue, 2007; Nakasa et al., 2008; Sonkoly et al., 2008; Stanczyk et al., 2008; Keiichiro et al., 2009; Tang et al., 2009; Larner-Svensson et al., 2010; Li et al., 2011).”
BackgroundNegative regulation of type I IFN signaling
Arimoto, K.-I., Miyauchi, S., Stoner, S. A., Fan, J.-B., & Zhang, D.-E. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.2mir0817-342r · Cited by 117
Mechanistic biomarkers for clinical decision making in rheumatic diseases
Robinson, W. H., Lindstrom, T. M., Cheung, R. K., & Sokolove, J. (2013) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2013.14 · Cited by 109
Lochhead, R. B., Ma, Y., Zachary, J. F., Baltimore, D., Zhao, J. L., Weis, J. H., O'Connell, R. M., & Weis, J. J. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004212 · Cited by 42
Metadata
- Authors
- Tang, Y., Luo, X., Cui, H., Ni, X., Yuan, M., Guo, Y., Huang, X., Zhou, H., de Vries, N., Tak, P. P., Chen, S., & Shen, N.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2009-03-30
- Volume
- 60
- Issue
- 4
- Pages
- 1065-1075
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2096388504
- Cited by
- 735
- References
- 51
- FWCI
- 37.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.